174 related articles for article (PubMed ID: 14984181)
1. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study.
Biedunkiewicz B; Tylicki L; Nieweglowski T; Burakowski S; Rutkowski B
Int J Artif Organs; 2004 Jan; 27(1):29-34. PubMed ID: 14984181
[TBL] [Abstract][Full Text] [Related]
2. No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
Tylicki L; Biedunkiewicz B; Rachon D; Nieweglowski T; Hak L; Chamienia A; Debska-Slizien A; Aleksandrowicz E; Mysliwska J; Rutkowski B
Mediators Inflamm; 2004 Dec; 13(5-6):377-80. PubMed ID: 15770057
[TBL] [Abstract][Full Text] [Related]
3. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.
Tylicki L; Nieweglowski T; Biedunkiewicz B; Chamienia A; Debska-Slizien A; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Int J Artif Organs; 2003 Apr; 26(4):297-303. PubMed ID: 12757028
[TBL] [Abstract][Full Text] [Related]
4. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study.
Tylicki L; Niew głowski T; Biedunkiewicz B; Burakowski S; Rutkowski B
Int J Artif Organs; 2001 Feb; 24(2):79-82. PubMed ID: 11256512
[TBL] [Abstract][Full Text] [Related]
5. Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients.
Tylicki L; Biedunkiewicz B; Nieweglowski T; Grabowska M; Chamienia A; Slizien AD; Rutkowski B
Artif Organs; 2004 May; 28(5):513-7. PubMed ID: 15156869
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.
Biedunkiewicz B; Lizakowski S; Tylicki L; Skiboeska A; Nieweglowski T; Chamienia A; Debska-Slizien A; Rutkowski B
Arch Med Res; 2006 Nov; 37(8):1034-7. PubMed ID: 17045123
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.
Biedunkiewicz B; Tylicki L; Rachon D; Hak L; Nieweglowski T; Chamienia A; Debska-Slizien A; Mysliwska J; Rutkowski B
Int J Artif Organs; 2004 Sep; 27(9):766-71. PubMed ID: 15521216
[TBL] [Abstract][Full Text] [Related]
8. Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.
Tylicki L; Biedunkiewicz B; Nieweglowski T; Chamienia A; Slizien AD; Luty J; Lysiak-Szydlowska W; Rutkowski B
Artif Organs; 2004 Feb; 28(2):234-7. PubMed ID: 14961966
[TBL] [Abstract][Full Text] [Related]
9. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
[TBL] [Abstract][Full Text] [Related]
10. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
[TBL] [Abstract][Full Text] [Related]
11. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.
Hernández A; Viñals M; Pablos A; Vilás F; Papadakos PJ; Wijeysundera DN; Bergese SD; Vives M
Int Immunopharmacol; 2021 Jan; 90():107261. PubMed ID: 33310665
[TBL] [Abstract][Full Text] [Related]
12. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
[TBL] [Abstract][Full Text] [Related]
13. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
[TBL] [Abstract][Full Text] [Related]
14. Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain.
Gardner AW; Montgomery PS; Afaq A
J Vasc Surg; 2007 Jul; 46(1):79-86. PubMed ID: 17540534
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
Mohler ER; Hiatt WR; Creager MA
Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
[TBL] [Abstract][Full Text] [Related]
16. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
Blume J; Kieser M; Hölscher U
Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
18. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
Kriessmann A
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
[TBL] [Abstract][Full Text] [Related]
20. Walking economy before and after the onset of claudication pain in patients with peripheral arterial disease.
Gardner AW; Ritti-Dias RM; Stoner JA; Montgomery PS; Scott KJ; Blevins SM
J Vasc Surg; 2010 Mar; 51(3):628-33. PubMed ID: 20206808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
